HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Issei Tokimatsu Selected Research

Trichosporonosis

3/2021Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
1/2015[Antifungal susceptibility and drug-resistant mechanism of Trichosporon].
12/2008[Trichosporonosis].
11/2008Quantitative PCR assay used to monitor serum Trichosporon asahii DNA concentrations in disseminated trichosporonosis.
1/2007The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
5/2006[Emerging deep-seated fungal infection, trichosporonosis].
1/2003[Pathogenesis of Trichosporon asahii and strategies for infectious control of disseminated trichosporonosis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Issei Tokimatsu Research Topics

Disease

9Pneumonia (Pneumonitis)
01/2020 - 01/2009
7Trichosporonosis
03/2021 - 01/2003
6Fever (Fevers)
03/2021 - 01/2006
6Infections
06/2015 - 01/2003
4Neutropenia
01/2015 - 01/2003
3Fungemia
03/2021 - 01/2007
3Communicable Diseases (Infectious Diseases)
09/2020 - 01/2015
3Diffuse panbronchiolitis
02/2019 - 03/2005
3Hematologic Neoplasms (Hematological Malignancy)
02/2015 - 01/2003
2Cross Infection (Nosocomial Infection)
12/2021 - 11/2008
2Neoplasms (Cancer)
03/2021 - 12/2006
2Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 01/2018
2Bacteremia
01/2019 - 08/2018
2Urinary Tract Infections (Urinary Tract Infection)
03/2018 - 02/2018
2Pulmonary Eosinophilia (Eosinophilic Pneumonia)
05/2009 - 03/2009
2Opportunistic Infections (Opportunistic Infection)
12/2008 - 05/2006
2Bronchiectasis
05/2008 - 06/2007
2Lymphadenopathy
05/2008 - 06/2007
2Invasive Pulmonary Aspergillosis
01/2007 - 01/2006
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
03/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2020
1COVID-19
01/2020
1Critical Illness (Critically Ill)
01/2020
1Dyspnea (Shortness of Breath)
01/2020
1Pulmonary Aspergillosis
01/2020
1Clostridium Infections
12/2019
1Pneumococcal Pneumonia
12/2019
1Drug-Related Side Effects and Adverse Reactions
12/2019
1Sinusitis
02/2019
1Septic Shock (Toxic Shock Syndrome)
01/2019
1Endophthalmitis (Ophthalmia)
01/2019
1Heart Diseases (Heart Disease)
01/2019
1Asthma (Bronchial Asthma)
01/2018
1Febrile Neutropenia
02/2015
1Breakthrough Infections
01/2015
1Bacterial Pneumonia
07/2014
1Respiratory Tract Infections (Respiratory Tract Infection)
07/2014
1Fibrosis (Cirrhosis)
12/2013
1Inflammation (Inflammations)
12/2013
1Aspiration Pneumonia
07/2013
1Frailty
07/2013
1Healthcare-Associated Pneumonia
07/2011
1Human Influenza (Influenza)
09/2010
1Eosinophilia
08/2009

Drug/Important Bio-Agent (IBA)

10Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 03/2005
6Antifungal AgentsIBA
03/2021 - 01/2003
4Voriconazole (Vfend)FDA LinkGeneric
01/2020 - 01/2006
4MacrolidesIBA
02/2019 - 03/2005
3Micafungin (FK463)FDA Link
03/2021 - 01/2006
3EchinocandinsIBA
03/2021 - 01/2006
3Fluconazole (Zonal)FDA LinkGeneric
03/2021 - 01/2003
3Itraconazole (Sporanox)FDA LinkGeneric
01/2020 - 01/2007
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 09/2007
3VancomycinFDA LinkGeneric
06/2015 - 01/2012
3Pharmaceutical PreparationsIBA
01/2012 - 01/2006
2liposomal amphotericin BFDA Link
03/2021 - 12/2018
2Ampicillin (Omnipen)FDA LinkGeneric
12/2019 - 12/2013
2TriazolesIBA
05/2006 - 01/2006
2Amphotericin B (Amphotericin)FDA LinkGeneric
05/2006 - 01/2006
1NucleotidesIBA
12/2021
1Anticonvulsants (Antiepileptic Drugs)IBA
03/2021
1favipiravirIBA
01/2020
1Immunoglobulin M (IgM)IBA
01/2020
1AntibodiesIBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Penicillins (Penicillin)FDA Link
12/2019
1Clarithromycin (Biaxin)FDA LinkGeneric
02/2019
1AlbuminsIBA
01/2019
1Carbapenems (Carbapenem Antibiotics)IBA
08/2018
1Procaterol (Pro-Air)IBA
01/2018
1Moxifloxacin (Avelox)FDA Link
01/2017
1AzolesIBA
01/2015
1Anti-Infective Agents (Microbicides)IBA
07/2014
1Levofloxacin (Levaquin)FDA Link
07/2014
1TeicoplaninIBA
01/2014
1CholesterolIBA
12/2013
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
12/2013
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2013
1Oxidoreductases (Dehydrogenase)IBA
12/2013
1SulbactamFDA LinkGeneric
12/2013
1garenoxacinIBA
12/2013
1polyglucosanIBA
02/2013
1N-hydroxy-2-aminopyreneIBA
07/2011
1Antiviral Agents (Antivirals)IBA
09/2010
1peramivirIBA
09/2010
1Zanamivir (Relenza)FDA Link
09/2010
1Oseltamivir (Tamiflu)FDA Link
09/2010
1Amantadine (Aman)FDA LinkGeneric
09/2010
1Immunoglobulin E (IgE)IBA
08/2009

Therapy/Procedure

14Therapeutics
03/2021 - 03/2005
6Drug Therapy (Chemotherapy)
03/2021 - 01/2003
2Mechanical Ventilators (Ventilator)
01/2019 - 08/2018
2Traction
05/2008 - 06/2007
1Artificial Respiration (Mechanical Ventilation)
01/2020
1Length of Stay
12/2019
1Lasers (Laser)
03/2018
1Dry Powder Inhalers
01/2018
1Oral Administration
01/2017
1Renal Dialysis (Hemodialysis)
01/2017
1Home Nursing (Nursing, Home)
07/2011